注册 | 登录
点击这里给我发消息
所有产品
  • 所有产品
  • 一抗
  • 裂解液
>   首页   >   产品   >   一抗   >   精选抗体   >   Anti-TNFRSF10A / TRAILR1 / CD261 Reference Antibody ( mapatumumab)   

Anti-TNFRSF10A / TRAILR1 / CD261 Reference Antibody ( mapatumumab)

Recombinant Antibody

     
  • 0 - Anti-TNFRSF10A / TRAILR1 / CD261 Reference Antibody ( mapatumumab) APR10535
    Anti-TNFRSF10A / TRAILR1 / CD261 Reference Antibody ( mapatumumab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
  • 0 - Anti-TNFRSF10A / TRAILR1 / CD261 Reference Antibody ( mapatumumab) APR10535
    The purity of Anti-TNFRSF10A / TRAILR1 / CD261 Reference Antibody ( mapatumumab) is 98.89%, determined by SEC-HPLC.
  • 产品详情
  • 实验流程
Product Information
Application
  • Applications Legend:
  • E=ELISA
  • WB=Western Blotting
  • IHC=Immunohistochemistry
  • IHC-P=Immunohistochemistry (Paraffin)
  • IP=Immunoprecipitation
  • IF=Immunofluorescence
  • IC=Immunochemistry
  • ICC=Immunocytochemistry
  • FC=Flow Cytometry
  • DB=Dot Blot
Functional assay, Kinetics (SPR), Kinetics (BLI), FACS, E, FTA
Primary Accession O00220
Reactivity Human
Clonality Monoclonal
Isotype IgG2SA
Calculated MW 50089 Da
Additional Information
Target/Specificity TNFRSF10A / TRAILR1 / CD261
Endotoxin < 0.001EU/ µg,determined by LAL method.
Conjugation Unconjugated
Expression system CHO
Format Purified monoclonal antibody supplied in PBS, pH6.0, without preservative.This antibody is purified through a protein A column.

For Research Use Only. Not For Use In Diagnostic Procedures.

Patent Notice: The variable region sequence of this antibody is derived from a published third-party patent. This product is manufactured independently as a Research Use Only (RUO) reagent and is not licensed, sponsored, or endorsed by the patent holder. It is intended solely for research purposes. Customers considering any commercial, diagnostic, or therapeutic use should independently evaluate freedom-to-operate with respect to relevant third-party patents.

Protein Information
Name TNFRSF10A
Synonyms APO2, DR4, TRAILR1
Function Receptor for the cytotoxic ligand TNFSF10/TRAIL (PubMed:26457518, PubMed:38532423). The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis (PubMed:19090789). Promotes the activation of NF-kappa-B (PubMed:9430227).
Cellular Location Cell membrane; Single-pass type I membrane protein. Membrane raft. Cytoplasm, cytosol. Note=Palmitoylation is required for association with membranes.
Tissue Location Widely expressed. High levels are found in spleen, peripheral blood leukocytes, small intestine and thymus, but also in K- 562 erythroleukemia cells, MCF-7 breast carcinoma cells and activated T-cells
Research Areas
FeedBack

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。

如有疑问,联系:0512-88856768 tech-china@abcepta.com.


我要评价